ACTG was established to broaden the scope of the AIDS research effort of the National Institute of Allergy and Infectious Diseases.
Joined August 2011
- Tweets4.7K
- Following708
- Followers1.4K
- Likes1.5K
📢 Exciting news from #ACTG! 🌍 They've published “Pitavastatin to Prevent Cardiovascular Disease in HIV Infection” in #NEJM. The #REPRIEVE trial shows pitavastatin calcium cuts risk of cardiovascular events by 35% in HIV patients over 5 years. #IAS2023
bit.ly/3OsgNLK
Join the #ACTG CSS! Applications open for 2023 membership. Seeking qualified individuals from U.S. and non-US sites. Focus on Western Hemisphere for equitable representation. Apply now! #HIVresearch
Learn more here: bit.ly/3DaFHsE
Kneeshe Parkinson, founder of RISE Impact a motivational speaker, certified life coach, trainer, facilitator, #activist, and The Washington University AIDS Clinical Trial Unit Community Advisory Board (#CAB) member featured in the current issue of #POZ
bit.ly/3ro2yOY
ACTG Network retweeted
While U.S. health agencies watch for a potential mpox rebound this summer, here’s a brief look at how the @ACTGNetwork launched a study on mpox treatment. #clinicaltrials #mpox ms.spr.ly/6016gsUcp
ACTG Network retweeted
Learn what can happen when great minds come together to advance science. Our new video highlights the extraordinary efforts of Accelerating #COVID19 Therapeutic Interventions and Vaccines (ACTIV), setting a framework for future preparedness and response. lnkd.in/dUjiAPKw
Check out the new website from ACTG and experience a community-focused and user-friendly platform. #ACTG #HIVresearch #clinicaltrials #ACTG2023
actgnetwork.org/
Exciting update from Dr. Currier on the state of the ACTG, highlighting a year of achievements. Stay tuned for more groundbreaking research! #ACTG #HIVresearch #scientificprogress #ACTG2023 #TB #HBV
@JudithCurrier
@JudithCurrier and @joseph_eron begin the #ACTG2023 Annual Meeting with a warm welcome to the Global Community Advisory Board (#GCAB) members. Communities are essential in shaping research that addresses local needs and concerns. #communityengagement #HIVresearch #TB #HepB
Exciting week ahead as the AIDS Clinical Trials Group 2023 meeting kicks off from June 13-16! Researchers and community members from around the world coming together to advance HIV research and treatments. Follow #ACTG2023 for updates!
#HIV #clinicaltrials #researchmatters
The #AASLD / #IDSA updated evidence-based guidance on #HCV infection diagnosis, management & treatment. From universal screening to management in unique populations, their latest update covers it all.
#HEPC #HepatitisC
ACTG Network retweeted
Welcome to our new website! View our new anthem video and others that illustrate the scientific and human impact of our work. Learn about our commitment to using team science and patient engagement to build bridges to biomedical breakthroughs. Explore now: fnih.org/
Meet Dr. Kristine Erlandson, an Associate Professor of Medicine in the Division of Infectious Diseases at the University of Colorado. Dr. Erlandson has been actively involved in the #ACTG since she was an infectious diseases fellow. Learn more: bit.ly/3VfV1fR
In 2021, approximately 650,000 people died from HIV-related causes and 1.5 million people acquired HIV. Learn more facts here: bit.ly/3mYYIdj
#HIVfacts #EndHIV #WHO
Meet Anne Njoroge, a CAB member for Eldoret-Kenya. She has been educating Kenyans about the importance of research, HIV prevention, and the elimination of HIV-related stigma and discrimination since 2010. Learn more here: bit.ly/3VfV1fR
#eldoretkenya #CAB #EndingHIV
An #ACTG #clinicaltrial may study experimental medications to treat #HIV and #AIDS, or to prevent or treat HIV-related infections.
New research shows early self-reported adherence to #HCV treatment could help identify those at higher risk of treatment failure. Full adherence associated with higher sustained virologic response rates: bit.ly/412UMWA
#ACTG #A5360 #MINMONTrial
Meet Gary Maartens, Professor of Medicine at the University of Cape Town (#UCT) -- a global leader in #tuberculosis and HIV #research. Their Division of Clinical Pharmacology has conducted phase 2/3 studies in #TB and #HIV for over 20 year! Learn more: bit.ly/3VfV1fR
New study finds that administering the combination of amubarvimab and romlusevimab significantly reduces the risk of hospitalization and death among nonhospitalized adults with mild to moderate #COVID19 at high risk for severe disease. Learn more here: bit.ly/44t2V9I
ACTG Network retweeted
Join us for an informative webinar on May 17th at 1:00 pm EST:
Hepatitis B and HIV Screening, Prevention and Management for African Immigrants and Refugees in the US: Barriers and Solutions.
Register here: ow.ly/riE350NNUoV
#hepatitisb #hepb #HBV
